Search

everythinglearnresearchcommunity

for

Search:↓

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Low iron, low thyroid function, and stress are linked to excessive hair shedding in women.

Spironolactone helps reduce hair growth in women with hirsutism but may cause menstrual irregularities.

Female pattern hair loss severity is linked to physical signs of high androgens, not blood hormone levels.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Hair loss in women linked to higher sexual dysfunction risk.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

The study concluded that low iron and vitamin D levels in women might play a role in chronic hair loss, despite no significant difference between those with and without hair loss.

The main cause of hirsutism in Algerian women is polycystic ovary syndrome, and those affected should be checked for related hormonal issues.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Spironolactone treatment increases the amount of testosterone available in the body.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.